9999999997-13-010840.txt : 20130618 9999999997-13-010840.hdr.sgml : 20130618 20130618144010 ACCESSION NUMBER: 9999999997-13-010840 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20130618 DATE AS OF CHANGE: 20130618 20130618 20130618 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Opko Health, Inc. CENTRAL INDEX KEY: 0000944809 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 752402409 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-33528 FILM NUMBER: 13919088 BUSINESS ADDRESS: STREET 1: 4400 BISCAYNE BLVD. STREET 2: SUITE 900 CITY: MIAMI STATE: FL ZIP: 33137 BUSINESS PHONE: 305-575-6015 MAIL ADDRESS: STREET 1: 4400 BISCAYNE BLVD. STREET 2: SUITE 900 CITY: MIAMI STATE: FL ZIP: 33137 FORMER COMPANY: FORMER CONFORMED NAME: eXegenics Inc DATE OF NAME CHANGE: 20040505 FORMER COMPANY: FORMER CONFORMED NAME: EXEGENICS INC DATE OF NAME CHANGE: 20011114 FORMER COMPANY: FORMER CONFORMED NAME: CYTOCLONAL PHARMACEUTICS INC /DE DATE OF NAME CHANGE: 19950503 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C0Y(#`@;V)J#3P\+TQI;F5AF4@-C(O5'EP92]84F5F+U=;,2`R(#%=/CYS=')E86T-"FC>8F)D$&!@ M8F#R`A(,4X`$XPT@P1(")-@>`XG/Y0Q,C`P'0+(,C.C$?\;)?P`"#`#7TP?D M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@ M("`@#0HV,2`P(&]B:@T\/"]#(#8Y+T9I;'1E8F!@8&%@8(IF``(>0P94P,@` MDN5H0!9C@6(&AAL,W`R7!E+U!A9V4^/@UE;F1O8FH--3(@,"!O8FH-/#PO1FEL=&5R+T9L871E M1&5C;V1E+T9I'E)KYME7K:$,Z'I-'OZE!?K34NT%O1#WIDN$F;H;)NM M&Y)(.JO*=C*I?CU<*'<,V(A@C&&"1[3.LEVQ?7FW*'9Y0V[SG^2NVF7E>[3= M9KNM-FV6%Z7ZVU. M&)VW^>X;X8FFBY>G''T!52&6NKER=4#>X'#O]8[FL5D6YIO=% M>5TV1=C/BKIIIYNL=D?NGP'==EVDG[/>02A%Y\\_6H"SJ)]SQ!7`NDI#'L$&0"9V!1]80VV5,K.%_;>S^V5TGMYL)`X:1(5I2P/P!"D"Y8N ML?_&^A#3KVV_]O80XX`FD0U!]0U`>RJ)$`R_"KZJ;XZ*9@8=%@4#`!YHT%IB"6,(D M',HCT[U)"3+$/"(M!?IU'/N7]*OWZ9>9\^CW3>:51YC7LM/$*^U)XCV7<]/_ MF7,E&^@3&`5LW(Z>LI9G4VZ839?#"\QN*OC>FXK?@7\7B*%_5V"ST1OS?A"+ ME,MYL`5J[N-BQI4Z#62"3-NS8F#'B(#B=R7\.S[TE^)PQ3T9,ZYT_12PMO`. M^4'&!;_3C`O5(^%R_HIP/2.\(MS4GL&W$0*CH70=QL#K3O&M5,D^W_+7?"NC M*QH+%.K_?6,).7LY%H_MU\?S>]H[1*D@_L(WOY\NS]\'+$(O;JU>O1D/7.AM<1FS["!'N&+702AY-8#'ZOPZ^*-Z"R9! M283K&;($SX8/Q+4*]EPP\X\SX("QB47DXK::!7DA@W@CD>0FI" MR$5QX.W;/2I9XW`7))S)HL]4)&/2>EQ79M,A4Q&5737.3V0O%67J>T,178TH M`U<,DW$U@,)%?.QR2#EB-*MS-+X(2OU)+_1D![]2+FGB"C[*E`_H!5-JA`_S MIQ*,Z00:BE-H@-7Q`1+')A@R2U76]?U.F&B(M.$Q&)(XHPQ@`I@,0L5+'&(< MDG92]MUPD3`2Y?WMO.$F9"Y[^I%("5? MH!]+'(@58_!O(Y@FA42%@!+3,T)\CT0O76`LURNIW5>:Q=+9:L=K>&4+C]E/SY[&_$XIL(X2M M0>JM(91*Y!HL\8ETV_Y3_>S%WF!/G4!""V#_'4%%::@@S')Q"]01[Q.:_GZRPGE39G1VPO#-V"^.:QNUV::5P,<[M[,QFS?9K MPP#FH,R7 M/8X4BG-(1_D7$JLVV"9CJ'*1'+`1";8)<+7B]\#!Q2Q`/S*:V"UNX6G)=@_P M15,UX[N5_:QSC,M0Q0-UH871I*=2OJ)%"V.$+78,%7S#[0RM+_-$L1*I(>< M;>7*T?B&_X:%H?0LK9<-C2&H++R&CP!!S3>X<4O(',#XGT!!<63D[:L9+M*. MB!-TR[P>=6#EN'C>XI@-Y760$Y()/1KRZ"D6TL!K"XG+^9TOM":<-1GPJ.$] MH=4Z.,>(0T([)C?RIJFJ#%4U2\G(W)JKW\DJN<0TXN_!X0UZO3KF'?NRQRE' M8A1?&)YI/383SU,F_F&Z&*$5,850B%/U5TJ6(8<&U9I:FU;B27I4`M`?X]*> M'AJ[0R0*4^P91HH)JC-(#88(QA.9'D0Z/9( MD_T:`.2$E[>4?0(Q<8U=40SQ8"-8FJK/'-1./@;FELN8C!:L10=T=O2?>SV MO#70T*F;>;>CHP>!1Z3_EDX#TP62[;X&,-".#@DOVOR-3]Y!I;MV:-FNW<`> MYZ.F:.S;.?9R`W<,V2QO47=E):3>5Q-1)OYB*:+LJ#*=6\S>9D_HF>L2P^63 MBD;TI*Z-)Z>\II&^AQ8D"0`X./PKH8JN((ZG147NEI-UY5#)UHYZ!,LV3G<" M@1;O#C!XGJ]WA@4>7/"_;N;-*X[,W4G6WU]U]S&M4?WOG;'>#?K`$UR@C\NW M]@1@"&5V2[JH0.4:%Z>91TK02*6^]7NK/F?O-1XVEDZ[NGG6V7ABN5_4 M5YWR9%'=92X79=Y9UKA5UI9(TBW2OM)T$NN'^.<:UK^83DS=Q&Y58T8S&,ALN1DRMS94F4H^Z,]HNOE2%NTT5WC[GXW?:"=<*>#TT?14$D' M!'-J%_G)SJAR%XI$V:[R%]VU+3M%XJA;I-T^6B*J6Z0;K7$W6N,V6DGDO.K] M)\``K[7;2@T*96YDCB MY,HDP,"0FU=2Y![D&!D1&:7`?IZ!C8&9`0P2DXL+'`,"?$#LO/R\5`8,\.T: M`R.(OJP+,@M3'B]@32XH*@'2!X#8*"6U.!E(?P'BS/*2`J`X8P*0+9*4#6:# MU(EDAP0Y`]D=0#9?26H%2(S!.;^@LB@S/:-$P=#2TE+!,24_*54AN+*X)#6W M6,$S+SF_J""_*+$D-06H%FH'"/"[%R56*K@GYN8F*ACI&9'H*&N2<`+32(!+_+<"C*B&?!B4Z$IO"E>0L"K(Y.`5Z/I`%Y"1P&\ MA':PE4\0$,#+5:(`7L:BN=-<-Q3`:ZJ*SL[<%;15=.TV[5BZZ68L!0K_?K`N M;]-5>2?OKOOG\J4=H'>>=QOW],NVZ[Z?5:D;>HF5,F(TO(1I!(VK4 M&DDC:RS@6?<22F&EL%)8*:P45@HKA97"2A&EB%)$*:(448HH190B2A&EB%*" M4H)2@E*"4H)2@E+"0KES&UK^N*W;EGLULMZ_O-[.W]`R8WETWG7]U$Z[OG/; MH>W1XK^<.@;O0.X+5:5S:J8U6!6HUFMS6HRJ]FL M-K:-$[)L6][6Y6U?WA;F;6/>5N9M9]Z6YFUK;%OC$]^8;8UM:VQ;8]L:V];8 MML:V-;:MB6U-;&MRXFK:UL2V)O^T]E.``0"*@?.[#0IE;F1S=')E86T-96YD M;V)J#3(@,"!O8FH-/#PO3&5N9W1H(#,Y,C(O4W5B='EP92]834PO5'EP92]- M971A9&%T83X^G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@] M(F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835`@0V]R92`U+C(M M8S`P,2`V,RXQ,SDT,SDL(#(P,3`O,#DO,C&UP.DUE=&%D871A M1&%T93XR,#$S+3`V+3$X5#$T.C,U+3`T.C`P/"]X;7`Z365T861A=&%$871E M/@H@("`@("`@("`\>&UP.D-R96%T;W)4;V]L/D%C&UP.D-R96%T;W)4;V]L/@H@("`@("`\+W)D9CI$ M97-C&UL;G,Z>&UP34T](FAT='`Z+R]N&%P+S$N,"]M;2\B/@H@("`@("`@("`\>&UP34TZ1&]C=6UE;G1)1#YU M=6ED.F4P,#&UP M34TZ1&]C=6UE;G1)1#X*("`@("`@("`@/'AM<$U-.DEN&UL;G,Z9&,] M(FAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D M9B\Q+C,O(CX*("`@("`@("`@/'!D9CI02`Q,"XP/"]P9&8Z4')O9'5C97(^"B`@("`@(#PO7!E+T]B:E-T;3X^J'5!:DZ@5^9Q]#<6(-3CS0#'^VG\8_BB,/25UT',!X"[NOJ_$?#&/)A3&> MH\HFYJDSD8ON]05IC@MJJ9[7S7**]01Q\IO*)S>#2F\B'+JWO;FQ`N&,X"(* M9U%;5GNQSU"#^`<=5&P:.$M6>AX=>'>]&GV,5'[]*$D'SHZ[.+;_H9:HH7*] M_A9@`%`=3PH-"F5N9'-T